Turner Investments’s Edwards Lifesciences EW Stock Holding History

Turner Investments’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-33,000	Closed	-$1.3M	–	129
2017 Q2	$1.3M	Buy	+33,000	New	+$1.2M	0.86%	41
2017 Q1	–	Sell	-117,390	Closed	-$3.67M	–	232
2016 Q4	$3.67M	Sell	117,390 -13,500	-10%	-$437K	1.48%	3
2016 Q3	$5.26M	Sell	130,890 -20,310	-13%	-$765K	1.74%	9
2016 Q2	$5.03M	Sell	151,200 -14,250	-9%	-$488K	1.58%	12
2016 Q1	$4.87M	Buy	+165,450	New	+$4.57M	1.32%	20
2015 Q1	–	Sell	-113,220	Closed	-$2.4M	–	451
2014 Q4	$2.4M	Hold	113,220	–	–	0.29%	105
2014 Q3	$1.93M	Buy	+113,220	New	+$1.79M	0.12%	255
2013 Q4	–	Sell	-218,340	Closed	-$2.53M	–	607
2013 Q3	$2.53M	Sell	218,340 -117,780	-35%	-$1.38M	0.04%	374
2013 Q2	$3.76M	Buy	+336,120	New	+$3.98M	0.05%	362

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Turner Investments's EW Position: Q3 2017 in Review

Turner Investments sold out of Edwards Lifesciences (EW) in Q3 2017, closing a stake of 33,000 shares — an estimated $1.3M sold.

Turner Investments first reported a position in EW in Q2 2013 and held it in 9 quarters. The position peaked at $5.26M in Q3 2016. 740 funds tracked by Wall St. Rank hold EW as of Q3 2017.

Turner Investments reported no remaining Edwards Lifesciences position as of Q3 2017 after selling out during the quarter.
Turner Investments sold 33,000 Edwards Lifesciences shares in Q3 2017, an estimated $1.3M.
Turner Investments first reported a position in Edwards Lifesciences in Q2 2013 and held it in 9 quarters.
Turner Investments's Edwards Lifesciences position peaked at $5.26M in Q3 2016.
740 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2017.

Based on Turner Investments's 13F filing for Q3 2017, filed 8 Nov 2017.